# Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria

> **NCT03087890** · PHASE4 · COMPLETED · sponsor: **University of Bergen** · enrollment: 537 (actual)

## Conditions studied

- HIV-1-infection
- Pneumocystis Pneumonia
- Opportunistic Infections
- Preventive Therapy
- Antibiotic Side Effect

## Interventions

- **DRUG:** Cotrimoxazole
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03087890
- **Lead sponsor:** University of Bergen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-03-30
- **Primary completion:** 2019-07-25
- **Final completion:** 2019-07-25
- **Target enrollment:** 537 (ACTUAL)
- **Last updated:** 2019-10-02

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03087890

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03087890, "Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant Bacteria". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT03087890. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*